Nobuyuki Ishige

Plasma globotriaosylsphingosine as a biomarker of Fabry disease

Tadayasu Togawa, Takashi Kodama, Toshihiro Suzuki et al. · Molecular Genetics and Metabolism · 2010 · 143 citations

Medicine, Biochemistry, Molecular Medicine +6

Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry

Teruo Kitagawa, Nobuyuki Ishige, Ken Suzuki et al. · Molecular Genetics and Metabolism · 2005 · 60 citations

Medicine, Biochemistry, Mass Spectrometric Analysis +12

Influence of antibody formation on reduction of globotriaosylceramide (GL-3) in urine from Fabry patients during agalsidase beta therapy

Toya Ohashi, Mio Sakuma, Teruo Kitagawa et al. · Molecular Genetics and Metabolism · 2007 · 50 citations

Life Sciences, Biochemistry, Immunology +5

Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST)

Osamu Saitô, Eiji Kusano, Tetsu Akimoto et al. · Clinical and Experimental Nephrology · 2015 · 38 citations

Medicine, Clinical Sciences, Nephrology +9

Newborn screening for carnitine palmitoyltransferase II deficiency using (C16 + C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity

Go Tajima, Keiichi Hara, Miyuki Tsumura et al. · Molecular Genetics and Metabolism · 2017 · 30 citations

Medicine, Biochemistry, Pediatrics +15